Hengxin Shambala Culture Co.,Ltd. (300081.SZ)
CNY 8.52
(-0.35%)
CNY 8.52
(-0.35%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 402.4 Million | 489.27 Million | 486.79 Million | 335.52 Million | 559.37 Million | 716.93 Million |
| Cost of Revenue | 320.69 Million | 384.61 Million | 348.81 Million | 293.06 Million | 326.7 Million | 378.33 Million |
| Gross Profit | 81.7 Million | 104.66 Million | 137.98 Million | 42.46 Million | 232.67 Million | 338.59 Million |
| Operating Expenses | 392.77 Million | 229.83 Million | 247.88 Million | 198.8 Million | 183.51 Million | 194.11 Million |
| Selling, General and Administrative Expenses | 128.75 Million | 119.42 Million | 118.42 Million | 104.09 Million | 88.77 Million | 97.64 Million |
| Research and Development Expenses | 79.64 Million | 50.04 Million | 60.95 Million | 53.1 Million | 29.63 Million | 19.43 Million |
| Other Expenses | 175.1 Million | 60.36 Million | 68.5 Million | 41.61 Million | 65.1 Million | 77.04 Million |
| Cost and Expenses | 704.19 Million | 614.44 Million | 596.7 Million | 491.86 Million | 510.21 Million | 572.45 Million |
| Operating Income | -301.79 Million | -125.17 Million | -109.9 Million | -156.34 Million | 39.65 Million | 216.66 Million |
| Interest Expense | 5.94 Million | 7.72 Million | 16.22 Million | 17.08 Million | 20.11 Million | 5.58 Million |
| Income Tax Expense | 3.3 Million | -4.09 Million | 905 Thousand | -13.28 Million | 40.29 Million | 16.24 Million |
| Earnings before Tax | -304.79 Million | -499.33 Million | -517.34 Million | -536.69 Million | 94.49 Million | 211.55 Million |
| Net Income | -281.32 Million | -495.24 Million | -518.25 Million | -523.4 Million | 56.33 Million | 198.31 Million |
| Earnings Per Share Basic | -0.47 | -0.82 | -0.98 | -1.00 | 0.11 | 0.37 |
| Earnings Per Share Diluted | -0.47 | -0.82 | -0.98 | -1.00 | 0.11 | 0.37 |
| Weighted Average Shares Outstanding | 604.74 Million | 604.79 Million | 529.3 Million | 525.38 Million | 527.45 Million | 530.4 Million |
| Weighted Average Shares Outstanding (Diluted) | 604.74 Million | 604.79 Million | 529.3 Million | 525.38 Million | 527.45 Million | 530.4 Million |
| Gross Margin | 0.20 | 0.21 | 0.28 | 0.13 | 0.42 | 0.47 |
| EBIT Margin | -0.38 | -0.10 | -0.08 | -0.43 | 0.13 | 0.42 |
| Profit Margin | -0.70 | -1.01 | -1.06 | -1.56 | 0.10 | 0.28 |
| EBITDA | -154.13 Million | -354.85 Million | -333.07 Million | -420.57 Million | 204.01 Million | 125.49 Million |
| Earnings Before Tax Margin | -0.75 | -0.26 | -0.23 | -0.47 | 0.07 | 0.30 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 99.28 Million | 76.28 Million | 88.27 Million | 402.4 Million | 126.13 Million | 134.03 Million |
| Cost of Revenue | 95.78 Million | 65.72 Million | 65.42 Million | 311.42 Million | 109.54 Million | 102.51 Million |
| Gross Profit | 3.5 Million | 10.56 Million | 22.84 Million | 90.97 Million | 16.58 Million | 31.51 Million |
| Operating Expenses | 70.66 Million | 59.17 Million | 57.73 Million | 262.71 Million | 77.1 Million | 66.79 Million |
| Selling, General and Administrative Expenses | 132.2 Million | 9.82 Million | 46.05 Million | - | -11.81 Million | 79.11 Million |
| Research and Development Expenses | 14.54 Million | 15.05 Million | 11.47 Million | - | 28.42 Million | 15.49 Million |
| Other Expenses | -76.09 Million | -444.21 Thousand | -32.03 Thousand | -2.99 Million | -1.25 Million | -76.5 Thousand |
| Cost and Expenses | 166.44 Million | 124.89 Million | 123.16 Million | 574.13 Million | 186.64 Million | 169.3 Million |
| Operating Income | -70.45 Million | -54.88 Million | -36.94 Million | -301.79 Million | -184.04 Million | -37.23 Million |
| Interest Expense | 1.27 Million | 1.3 Million | 1.18 Million | 5.94 Million | 1.54 Million | 1.85 Million |
| Income Tax Expense | 150.91 Thousand | -1.43 Million | 145.54 Thousand | 3.3 Million | 1.82 Million | -92.62 Thousand |
| Earnings before Tax | -70.41 Million | -55.32 Million | -36.97 Million | -304.79 Million | -185.29 Million | -37.3 Million |
| Net Income | -64.46 Million | -47.74 Million | -30.74 Million | -281.32 Million | -180.95 Million | -34.65 Million |
| Earnings Per Share Basic | -0.11 | -0.08 | -0.05 | - | -0.30 | -0.06 |
| Earnings Per Share Diluted | -0.11 | -0.08 | -0.05 | - | -0.30 | -0.06 |
| Weighted Average Shares Outstanding | 604.79 Million | 604.79 Million | 605.22 Million | 604.74 Million | 605.05 Million | 604.79 Million |
| Weighted Average Shares Outstanding (Diluted) | 604.79 Million | 604.79 Million | 605.22 Million | 604.74 Million | 605.05 Million | 604.79 Million |
| Gross Margin | 0.04 | 0.14 | 0.26 | 0.23 | 0.13 | 0.24 |
| EBIT Margin | -0.70 | -0.66 | -0.39 | - | -0.47 | -0.27 |
| Profit Margin | -0.65 | -0.63 | -0.35 | -0.70 | -1.43 | -0.26 |
| EBITDA | -69.13 Million | -50.38 Million | -34.52 Million | - | -59.73 Million | -35.93 Million |
| Earnings Before Tax Margin | -0.71 | -0.72 | -0.42 | -0.75 | -1.46 | -0.28 |
SYNE3
000983
300845
IRVRF
WINT
PSYC